You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd
Bharat Immunological & Biological Corporation Ltd.
| BSE: 524663 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE994B01014 |
| BSE 10:25 | 29 Jun | 27.95 |
2.50 (9.82%) |
OPEN
24.15 |
HIGH
27.95 |
LOW
24.15 |
| NSE 05:30 | 01 Jan | Bharat Immunological & Biological Corporation Ltd |
| OPEN | 24.15 |
| PREVIOUS CLOSE | 25.45 |
| VOLUME | 52612 |
| 52-Week high | 78.15 |
| 52-Week low | 22.80 |
| P/E | |
| Mkt Cap.(Rs cr) | 121 |
| Buy Price | 27.95 |
| Buy Qty | 46722.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bharat Immunological & Biological Corporation Ltd. (BHARATIMMUNOLOG) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 518.10 | -3.20 | -0.61 | 15823.68 |
| Cipla | 927.45 | -17.25 | -1.83 | 13900.58 |
| Dr Reddy's Labs | 4380.05 | 5.40 | 0.12 | 13349.10 |
| Sun Pharma.Inds. | 827.15 | -0.80 | -0.10 | 12803.21 |
| Lupin | 628.15 | -5.40 | -0.85 | 11055.93 |
| Apollo Hospitals | 3804.00 | -34.70 | -0.90 | 9153.00 |
| Zydus Lifesci. | 356.80 | -0.95 | -0.27 | 7790.40 |
| Glenmark Pharma. | 384.85 | -2.60 | -0.67 | 7567.93 |
| Alkem Lab | 2946.05 | -44.25 | -1.48 | 7219.68 |
| Divi's Lab. | 3567.65 | -46.30 | -1.28 | 6798.61 |
| Torrent Pharma. | 2850.15 | -32.00 | -1.11 | 6450.83 |
| Ipca Labs. | 888.55 | -13.65 | -1.51 | 5114.11 |
| Alembic Pharma | 732.15 | -6.10 | -0.83 | 5051.44 |
| Laurus Labs | 468.35 | -0.35 | -0.07 | 4707.04 |
| Abbott India | 18146.15 | 20.05 | 0.11 | 4310.02 |
| Gland Pharma | 2683.85 | 36.20 | 1.37 | 3462.88 |
| Glaxosmi. Pharma | 1505.00 | 6.45 | 0.43 | 3193.74 |
| Granules India | 276.70 | 1.30 | 0.47 | 3134.98 |
| Sanofi India | 6422.45 | 16.30 | 0.25 | 2956.60 |
| Ajanta Pharma | 1239.55 | -1.35 | -0.11 | 2718.59 |
Quick Links for Bharat Immunological & Biological Corporation:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
